hydroxychloroquine has been researched along with Emergencies in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Emergencies: Situations or conditions requiring immediate intervention to avoid serious adverse results.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater." | 6.66 | Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. ( Baguley, DM; Kasbekar, AV; Prayuenyong, P, 2020) |
| " The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater." | 2.66 | Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. ( Baguley, DM; Kasbekar, AV; Prayuenyong, P, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piszczatoski, CR | 1 |
| Powell, J | 1 |
| Prayuenyong, P | 1 |
| Kasbekar, AV | 1 |
| Baguley, DM | 1 |
| Thorp, HH | 1 |
| Lazovic, B | 1 |
| Zlatkovic-Svenda, M | 1 |
| Jasarovic, D | 1 |
| Stevanovic, D | 1 |
| Bozkirli, DE | 1 |
| Kozanoglu, I | 1 |
| Bozkirli, E | 1 |
| Yucel, E | 1 |
| Merino Argumánez, C | 1 |
| Sáez de La Fuente, I | 1 |
| Molina Collado, Z | 1 |
| Suárez Pita, D | 1 |
| Mestre Gómez, B | 1 |
| Sanchez Izquierdo, JA | 1 |
2 reviews available for hydroxychloroquine and Emergencies
| Article | Year |
|---|---|
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
Topics: Antimalarials; Antiviral Agents; Chloroquine; COVID-19 Drug Treatment; Emergencies; Hearing Loss; Hu | 2020 |
Hydroxychloroquine, a potentially lethal drug.
Topics: Adult; Anisocoria; Coma; Connective Tissue Diseases; Emergencies; Female; Heart Arrest; Humans; Hydr | 2017 |
4 other studies available for hydroxychloroquine and Emergencies
| Article | Year |
|---|---|
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
Topics: Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Emergencies | 2020 |
Not throwing away our shot.
Topics: Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Emergencies; Humans; Hydr | 2020 |
Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis.
Topics: Acute Disease; Aged; Chest Pain; Diagnosis, Differential; Dyspnea; Emergencies; Female; Fever; Human | 2018 |
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Em | 2013 |